Longacting injectable drugs in the maintenance therapy of patients with schizophrenia

Standard

Longacting injectable drugs in the maintenance therapy of patients with schizophrenia. / Petrova, Nataliia ; Serazetdinova, Valeria.

In: Consortium Psychiatricum , Vol. 1, No. 2, 2020, p. 53-62.

Research output: Contribution to journal › Article › peer-review

BibTeX

@article{11cfb56d2efa490bb082800c24898954,

title = "Longacting injectable drugs in the maintenance therapy of patients with schizophrenia",

abstract = "This article discusses case reports of treatment with paliperidone palmitate in comparison with data from recent publications. Second-generation long-acting injectable antipsychotics have been shown to provide better control of psychiatric manifestations, reduce the severity of negative symptoms, improve social functioning and quality of life of patients and relatives, and reduce the burden of disease for both the healthcare system and the caregivers. The case reports presented in this article demonstrate better quality of remission in schizophrenia patients treated with one- monthly and three-monthly paliperidone palmitate formulations, due to higher effi in preventing relapses, better safety and good tolerability regardless of patient age.",

keywords = "paliperidone palmitate, schizophrenia, long-acting injectable, personal recovery",

author = "Nataliia Petrova and Valeria Serazetdinova",

note = "Petrova N.N., Serazetdinova V.S. Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia. Consortium Psychiatricum. 2020;1(2):53-62. https://doi.org/10.17650/2712-7672-2020-1-2-53-62",

year = "2020",

doi = "10.17650/2712-7672-2020-1-2-53-62",

language = "English",

volume = "1",

pages = "53--62",

journal = "Consortium Psychiatricum",

issn = "2712-7672",

publisher = "Eco-Vector LLC",

number = "2",

}

RIS

TY - JOUR

T1 - Longacting injectable drugs in the maintenance therapy of patients with schizophrenia

AU - Petrova, Nataliia

AU - Serazetdinova, Valeria

N1 - Petrova N.N., Serazetdinova V.S. Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia. Consortium Psychiatricum. 2020;1(2):53-62. https://doi.org/10.17650/2712-7672-2020-1-2-53-62

PY - 2020

Y1 - 2020

N2 - This article discusses case reports of treatment with paliperidone palmitate in comparison with data from recent publications. Second-generation long-acting injectable antipsychotics have been shown to provide better control of psychiatric manifestations, reduce the severity of negative symptoms, improve social functioning and quality of life of patients and relatives, and reduce the burden of disease for both the healthcare system and the caregivers. The case reports presented in this article demonstrate better quality of remission in schizophrenia patients treated with one- monthly and three-monthly paliperidone palmitate formulations, due to higher effi in preventing relapses, better safety and good tolerability regardless of patient age.

AB - This article discusses case reports of treatment with paliperidone palmitate in comparison with data from recent publications. Second-generation long-acting injectable antipsychotics have been shown to provide better control of psychiatric manifestations, reduce the severity of negative symptoms, improve social functioning and quality of life of patients and relatives, and reduce the burden of disease for both the healthcare system and the caregivers. The case reports presented in this article demonstrate better quality of remission in schizophrenia patients treated with one- monthly and three-monthly paliperidone palmitate formulations, due to higher effi in preventing relapses, better safety and good tolerability regardless of patient age.

KW - paliperidone palmitate

KW - schizophrenia

KW - long-acting injectable

KW - personal recovery

U2 - 10.17650/2712-7672-2020-1-2-53-62

DO - 10.17650/2712-7672-2020-1-2-53-62

M3 - Article

VL - 1

SP - 53

EP - 62

JO - Consortium Psychiatricum

JF - Consortium Psychiatricum

SN - 2712-7672

IS - 2

ER -

ID: 71527870